Literature DB >> 9247316

Characterization of murine Flt4 ligand/VEGF-C.

L J Fitz1, J C Morris, P Towler, A Long, P Burgess, R Greco, J Wang, R Gassaway, E Nickbarg, S Kovacic, A Ciarletta, J Giannotti, H Finnerty, R Zollner, D R Beier, L V Leak, K J Turner, C R Wood.   

Abstract

Flt4 is a receptor protein tyrosine kinase that is expressed in the adult lymphatic endothelium and high endothelial venules. We have used a BIAcore assay to identify rodent and human cell conditioned media containing the ligand of Flt4 (Flt4-L). Receptor-based affinity chromatography was used to purify this growth factor, followed by amino acid sequencing and molecular cloning of the murine cDNA, the orthologue of human vascular endothelial growth factor-C and vascular endothelial growth factor related protein. The murine flt4-L gene was localized to chromosome 8 and demonstrated to be widely expressed. Flt4-L was found to have a hydrophobic signal sequence and a pro-peptide-like sequence that is removed to generate the mature N-terminus. In addition, the C-terminal region of Flt4-L has four repeats of a cysteine-rich motif that is presumably also proteolytically processed to generate the 21000 Mr polypeptide subunit of the Flt4-L homodimer. Recombinant Flt4-L activated Flt4 as judged by induction of tyrosyl phosphorylation, and induced mitogenesis in vitro of lymphatic endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247316     DOI: 10.1038/sj.onc.1201191

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage.

Authors:  A Horner; N J Bishop; S Bord; C Beeton; A W Kelsall; N Coleman; J E Compston
Journal:  J Anat       Date:  1999-05       Impact factor: 2.610

2.  FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status.

Authors:  Victoria Moreno-Manzano; Francisco J Rodríguez-Jiménez; Jose L Aceña-Bonilla; Santos Fustero-Lardíes; Slaven Erceg; Joaquin Dopazo; David Montaner; Miodrag Stojkovic; Jose M Sánchez-Puelles
Journal:  J Biol Chem       Date:  2009-11-06       Impact factor: 5.157

3.  Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors:  Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal:  Sensors (Basel)       Date:  2009-08-20       Impact factor: 3.576

4.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

5.  VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma.

Authors:  Li-Cheng Du; Xian-Cheng Chen; Dong Wang; Yan-Jun Wen; Chun-Ting Wang; Xue-Mei Wang; Bing Kan; Yu-Quan Wei; Xia Zhao
Journal:  Reprod Biol Endocrinol       Date:  2014-02-06       Impact factor: 5.211

Review 6.  The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.

Authors:  Jui-Chieh Chen; Yi-Wen Chang; Chih-Chen Hong; Yang-Hao Yu; Jen-Liang Su
Journal:  Int J Mol Sci       Date:  2012-12-20       Impact factor: 5.923

7.  Serum biomarkers VEGF-C and IL-6 are associated with severe human Peripheral Artery Stenosis.

Authors:  Jiexia Chen; Lei Han; Xiaoyan Xu; Haiqin Tang; Hongyan Wang; Bin Wei
Journal:  J Inflamm (Lond)       Date:  2015-08-18       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.